186 related articles for article (PubMed ID: 23410495)
21. Hostility scores are associated with increased risk of cardiovascular events in women undergoing coronary angiography: a report from the NHLBI-Sponsored WISE Study.
Olson MB; Krantz DS; Kelsey SF; Pepine CJ; Sopko G; Handberg E; Rogers WJ; Gierach GL; McClure CK; Merz CN;
Psychosom Med; 2005; 67(4):546-52. PubMed ID: 16046366
[TBL] [Abstract][Full Text] [Related]
22. Depression Symptom Patterns as Predictors of Metabolic Syndrome and Cardiac Events in Symptomatic Women with Suspected Myocardial Ischemia: The Women's Ischemia Syndrome Evaluation (WISE and WISE-CVD) Projects.
Virzi NE; Krantz DS; Bittner VA; Merz CNB; Reis SE; Handberg EM; Pepine CJ; Vaccarino V; Rutledge T
Heart Mind (Mumbai); 2022; 6(4):254-261. PubMed ID: 36994354
[TBL] [Abstract][Full Text] [Related]
23. Detailed angiographic analysis of women with suspected ischemic chest pain (pilot phase data from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation [WISE] Study Angiographic Core Laboratory).
Sharaf BL; Pepine CJ; Kerensky RA; Reis SE; Reichek N; Rogers WJ; Sopko G; Kelsey SF; Holubkov R; Olson M; Miele NJ; Williams DO; Merz CN;
Am J Cardiol; 2001 Apr; 87(8):937-41; A3. PubMed ID: 11305981
[TBL] [Abstract][Full Text] [Related]
24. Weight cycling and cardiovascular outcome in women with suspected ischemia: A report from the NHLBI-sponsored WISE Study.
Bairey Merz CN; Olson MB; Kelsey SF; Bittner V; Reis SE; Reichek N; Handberg E
PLoS One; 2018; 13(12):e0207223. PubMed ID: 30507935
[TBL] [Abstract][Full Text] [Related]
25. Electrocardiographic predictors of cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) study.
Triola B; Olson MB; Reis SE; Rautaharju P; Merz CN; Kelsey SF; Shaw LJ; Sharaf BL; Sopko G; Saba S
J Am Coll Cardiol; 2005 Jul; 46(1):51-6. PubMed ID: 15992635
[TBL] [Abstract][Full Text] [Related]
26. Association of Sex With Severity of Coronary Artery Disease, Ischemia, and Symptom Burden in Patients With Moderate or Severe Ischemia: Secondary Analysis of the ISCHEMIA Randomized Clinical Trial.
Reynolds HR; Shaw LJ; Min JK; Spertus JA; Chaitman BR; Berman DS; Picard MH; Kwong RY; Bairey-Merz CN; Cyr DD; Lopes RD; Lopez-Sendon JL; Held C; Szwed H; Senior R; Gosselin G; Nair RG; Elghamaz A; Bockeria O; Chen J; Chernyavskiy AM; Bhargava B; Newman JD; Hinic SB; Jaroch J; Hoye A; Berger J; Boden WE; O'Brien SM; Maron DJ; Hochman JS;
JAMA Cardiol; 2020 Jul; 5(7):773-786. PubMed ID: 32227128
[TBL] [Abstract][Full Text] [Related]
27. Lipid-lowering medication use and aggression scores in women: a report from the NHLBI-sponsored WISE study.
Olson MB; Kelsey SF; Matthews KA; Bairey Merz CN; Eteiba W; McGorray SP; Cornell CE; Vido DA; Muldoon MF
J Womens Health (Larchmt); 2008 Mar; 17(2):187-94. PubMed ID: 18321170
[TBL] [Abstract][Full Text] [Related]
28. DHEA-S levels and cardiovascular disease mortality in postmenopausal women: results from the National Institutes of Health--National Heart, Lung, and Blood Institute (NHLBI)-sponsored Women's Ischemia Syndrome Evaluation (WISE).
Shufelt C; Bretsky P; Almeida CM; Johnson BD; Shaw LJ; Azziz R; Braunstein GD; Pepine CJ; Bittner V; Vido DA; Stanczyk FZ; Bairey Merz CN
J Clin Endocrinol Metab; 2010 Nov; 95(11):4985-92. PubMed ID: 20739385
[TBL] [Abstract][Full Text] [Related]
29. Ten-Year Mortality in the WISE Study (Women's Ischemia Syndrome Evaluation).
Kenkre TS; Malhotra P; Johnson BD; Handberg EM; Thompson DV; Marroquin OC; Rogers WJ; Pepine CJ; Bairey Merz CN; Kelsey SF
Circ Cardiovasc Qual Outcomes; 2017 Dec; 10(12):. PubMed ID: 29217675
[TBL] [Abstract][Full Text] [Related]
30. Inflammatory biomarkers as predictors of heart failure in women without obstructive coronary artery disease: A report from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE).
AlBadri A; Lai K; Wei J; Landes S; Mehta PK; Li Q; Johnson D; Reis SE; Kelsey SF; Bittner V; Sopko G; Shaw LJ; Pepine CJ; Bairey Merz CN
PLoS One; 2017; 12(5):e0177684. PubMed ID: 28542263
[TBL] [Abstract][Full Text] [Related]
31. Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study.
Pepine CJ; Anderson RD; Sharaf BL; Reis SE; Smith KM; Handberg EM; Johnson BD; Sopko G; Bairey Merz CN
J Am Coll Cardiol; 2010 Jun; 55(25):2825-32. PubMed ID: 20579539
[TBL] [Abstract][Full Text] [Related]
32. Healthcare utilization and cost of care in elderly breast cancer patients enrolled in SWOG clinical trials.
Hershman DL; Till C; Wright JD; Accordino M; Vaidya R; Barlow WE; Ramsey S; Unger JM
Breast Cancer Res Treat; 2020 Jun; 181(2):455-463. PubMed ID: 32306168
[TBL] [Abstract][Full Text] [Related]
33. Sudden Cardiac Death in Women With Suspected Ischemic Heart Disease, Preserved Ejection Fraction, and No Obstructive Coronary Artery Disease: A Report From the Women's Ischemia Syndrome Evaluation Study.
Mehta PK; Johnson BD; Kenkre TS; Eteiba W; Sharaf B; Pepine CJ; Reis SE; Rogers WJ; Kelsey SF; Thompson DV; Bittner V; Sopko G; Shaw LJ; Bairey Merz CN
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862961
[TBL] [Abstract][Full Text] [Related]
34. Safety of coronary reactivity testing in women with no obstructive coronary artery disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study.
Wei J; Mehta PK; Johnson BD; Samuels B; Kar S; Anderson RD; Azarbal B; Petersen J; Sharaf B; Handberg E; Shufelt C; Kothawade K; Sopko G; Lerman A; Shaw L; Kelsey SF; Pepine CJ; Merz CN
JACC Cardiovasc Interv; 2012 Jun; 5(6):646-53. PubMed ID: 22721660
[TBL] [Abstract][Full Text] [Related]
35. Even "WISE-R?"-an Update on the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation.
Barsky L; Merz CNB; Wei J; Shufelt C; Handberg E; Pepine C; Rutledge T; Reis S; Doyle M; Rogers W; Shaw L; Sopko G
Curr Atheroscler Rep; 2020 Jun; 22(8):35. PubMed ID: 32556630
[TBL] [Abstract][Full Text] [Related]
36. Psychological stress, cardiac symptoms, and cardiovascular risk in women with suspected ischaemia but no obstructive coronary disease.
Gomez MA; Merz NB; Eastwood JA; Pepine CJ; Handberg EM; Bittner V; Mehta PK; Krantz DS; Vaccarino V; Eteiba W; Rutledge T
Stress Health; 2020 Aug; 36(3):264-273. PubMed ID: 31957961
[TBL] [Abstract][Full Text] [Related]
37. Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project.
Gulati M; Cooper-DeHoff RM; McClure C; Johnson BD; Shaw LJ; Handberg EM; Zineh I; Kelsey SF; Arnsdorf MF; Black HR; Pepine CJ; Merz CN
Arch Intern Med; 2009 May; 169(9):843-50. PubMed ID: 19433695
[TBL] [Abstract][Full Text] [Related]
38. Stable angina in women: lessons from the National Heart, Lung and Blood Institute-sponsored Women’s Ischemia Syndrome Evaluation.
Merz CN; Shaw LJ
J Cardiovasc Med (Hagerstown); 2011 Feb; 12(2):85-7. PubMed ID: 21228716
[TBL] [Abstract][Full Text] [Related]
39. Angina Hospitalization Rates in Women With Signs and Symptoms of Ischemia But no Obstructive Coronary Artery Disease: A Report from the WISE (Women's Ischemia Syndrome Evaluation) Study.
Aldiwani H; Zaya M; Suppogu N; Quesada O; Johnson BD; Mehta PK; Shufelt C; Petersen J; Azarbal B; Samuels B; Anderson RD; Shaw LJ; Kar S; Handberg E; Kelsey SF; Pepine CJ; Bairey Merz CN
J Am Heart Assoc; 2020 Feb; 9(4):e013168. PubMed ID: 32063125
[TBL] [Abstract][Full Text] [Related]
40. TIMI frame count and adverse events in women with no obstructive coronary disease: a pilot study from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE).
Petersen JW; Johnson BD; Kip KE; Anderson RD; Handberg EM; Sharaf B; Mehta PK; Kelsey SF; Merz CN; Pepine CJ
PLoS One; 2014; 9(5):e96630. PubMed ID: 24800739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
